LY-3457263
- Generic Name
- LY-3457263
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- First Posted Date
- 2025-03-27
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 240
- Registration Number
- NCT06897475
- Locations
- 🇺🇸
Helios Clinical Research - Phoenix, Phoenix, Arizona, United States
🇺🇸Wolverine Clinical Trials, Tustin, California, United States
🇺🇸Renstar Medical Research, Ocala, Florida, United States
A Study of LY3457263 in Obese Participants
Phase 1
Completed
- Conditions
- OverweightObesity
- Interventions
- First Posted Date
- 2022-10-17
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 38
- Registration Number
- NCT05582096
- Locations
- 🇺🇸
LabCorp CRU, Inc., Daytona Beach, Florida, United States
A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
Phase 1
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2022-05-17
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 94
- Registration Number
- NCT05377333
- Locations
- 🇺🇸
Qps-Mra, Llc, South Miami, Florida, United States
🇺🇸CenExel-HRI, Berlin, New Jersey, United States
🇺🇸Pinnacle Research Group, LLC, Anniston, Alabama, United States
A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes
Phase 1
Completed
- Conditions
- Type 2 DiabetesHealthy
- Interventions
- First Posted Date
- 2020-11-23
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 67
- Registration Number
- NCT04641312
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung, Neuss, Nordrhein-Westfalen, Germany
🇩🇪Profil Mainz, Mainz, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath